| Brenda Borges, | |
|
2067 Massachusetts Ave, Cambridge, MA 02140-1340 | |
| (617) 575-5570 | |
| Not Available |
| Full Name | Brenda Borges |
|---|---|
| Gender | Female |
| Speciality | Licensed Vocational Nurse |
| Location | 2067 Massachusetts Ave, Cambridge, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497282123 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164X00000X | Licensed Vocational Nurse | 164X00000X (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brenda Borges, 625 Thomas Burgin Pkwy Apt 239, Quincy, MA 02169-7650 Ph: () - | Brenda Borges, 2067 Massachusetts Ave, Cambridge, MA 02140-1340 Ph: (617) 575-5570 |
News Archive
Sundia MediTech Company, Ltd., a leading pharmaceutical R&D outsourcing Service Company in China, announced that the company has been officially recognized as a technically-advanced service enterprise in Shanghai.
People fleeing across the Mediterranean by boat face many dangers. In a paper now published in the renowned medical journal Lancet, researchers working at the Technical University of Munich's Klinikum rechts der Isar, Städtisches Klinikum München GmbH, and Jamaica Hospital, New York, report for the first time on acute and sometimes fatal cases of pneumonitis resulting from the ingestion of fuel.
Global regenerative medicine company Mesoblast Limited (ASX:MSB) has announced that its Phase 2 clinical trial investigating the use of allogeneic, or off-the-shelf, Mesenchymal Precursor Cells (MPCs) for non-surgical restoration of degenerated intervertebral discs and treatment of low back pain has enrolled 50% of the total study patients. This rapid rate of enrolment attests to the major unmet medical need and to the relative simplicity of Mesoblast's non-surgical procedure. Mesoblast expects to complete full enrolment by early third quarter.
OXIS INTERNATIONAL, INC. (Pink Sheets: OXIS, Paris: OXI) announced today that Ergoplex™, its commercial anti-inflammatory product using its patented compound, Ergothioneine, a powerful antioxidant, has shown very good acceptance in a recent direct mail test.
Malaria was eliminated from southern and southeastern Brazil over 50 years ago, but a number of cases each year in areas of the Atlantic Forest prompted researchers to investigate the possibility of zoonotic transmission - where human beings become infected, via a mosquito bite, with a malaria parasite that usually infects monkeys.
› Verified 6 days ago
Aidanni Headley, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 119 Windsor St, Cambridge, MA 02139 Phone: 617-665-3600 |